Loading…
ICU Medical, Inc. is projected to rise to $204.74 by 2027, a +33% move from its current price of $154.42. ICUI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $151.39 | $154.49 | $157.65 | +0.04% |
| Jul 14 | $150.19 | $154.55 | $159.05 | +0.09% |
| Jul 15 | $149.29 | $154.62 | $160.15 | +0.13% |
| Jul 16 | $148.54 | $154.69 | $161.09 | +0.17% |
| Jul 17 | $147.90 | $154.76 | $161.93 | +0.22% |
| Jul 18 | $147.32 | $154.83 | $162.71 | +0.26% |
| Jul 19 | $146.80 | $154.89 | $163.43 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $146.80 | $154.89 | $163.43 | +0.31% |
| Week 2 | $144.02 | $155.37 | $167.61 | +0.61% |
| Week 3 | $142.02 | $155.84 | $171.01 | +0.92% |
| Week 4 | $140.42 | $156.32 | $174.02 | +1.23% |
| Week 5 | $139.08 | $156.80 | $176.78 | +1.54% |
| Week 6 | $137.91 | $157.28 | $179.36 | +1.85% |
| Week 7 | $136.89 | $157.76 | $181.81 | +2.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClave for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. It provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
ICU Medical was founded in 1984 and is based in San Clemente, California.
ICU Medical, Inc. is categorized in Healthcare and operates as a medical products company.
The current price is $154.97, the market cap is $3.87B, and the stock ranks 1532.
The forecasted price outlook is bullish over the long term, with 2026 average $154.97, 2027 average $205.82, 2028 average $223.31, 2029 average $243.63, 2030 average $257.18, 2040 average $724.20, and 2050 average $1,238.89.
A major floor 25.2% below — a decisive break under it would weaken the trend.
The nearest floor, 15.5% below — buyers have tended to step in here.
The nearest ceiling, 3.2% above — a clean break opens room to run.
A major ceiling 14.7% above — clearing it would confirm fresh momentum.
Key ICUI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICUI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $155.53 | Sell | $154.29 | Buy |
| MA 10 | $152.39 | Buy | $152.06 | Buy |
| MA 20 | $146.84 | Buy | $147.71 | Buy |
| MA 50 | $135.57 | Buy | $140.30 | Buy |
| MA 100 | $134.18 | Buy | $137.35 | Buy |
| MA 200 | $136.18 | Buy | $136.72 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.63 | Neutral |
| Stoch RSI (14) | 48.92 | Neutral |
| CCI (20) | 87.59 | Neutral |
| Williams %R (14) | -20.95 | Info |
| MACD (12,26,9) | 0.50 | Buy |
| ROC (12) | 13.95 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 79.05 | Neutral |
| TRIX (15) | 0.54 | Buy |
| Awesome (5,34) | 13.39 | Buy |
| Ultimate (7,14,28) | 64.18 | Neutral |
| Momentum (10) | 5.59 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 155.84 | Sell |
| ADX (14) | 25.07 | Buy |
| ATR (14) | 3.03 | Info |
The 30-day technical picture shows bullish sentiment with RSI14 at 70, and price near resistance at $154.97. The SMA50 is $132.43 and the SMA200 is $135.57, suggesting positive momentum.
The stock trades within a 30-day range of $135.63 to $177.07, with a support at $129.31 and a resistance at $154.97.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $115.45 | $154.42 | $211.57 | 0% | Neutral | |
| $166.89 | $204.74 | $263.20 | +33% | Bullish | |
| $178.08 | $222.92 | $294.84 | +44% | Bullish | |
| $193.35 | $246.08 | $332.86 | +59% | Bullish | |
| $199.04 | $257.04 | $354.35 | +66% | Bullish | |
| $221.23 | $289.49 | $405.79 | +87% | Bullish | |
| $261.22 | $346.01 | $492.36 | +124% | Bullish | |
| $284.62 | $381.32 | $550.06 | +147% | Bullish | |
| $322.04 | $436.13 | $637.10 | +182% | Bullish | |
| $342.09 | $468.07 | $691.82 | +203% | Bullish | |
| $514.30 | $736.81 | $1,144.36 | +377% | Bullish | |
| $824.51 | $1,275.61 | $2,131.75 | +726% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $115.45 | $154.42 | $187.23 | +0.00% |
| August 2026 | $138.08 | $161.88 | $194.07 | +4.83% |
| September 2026 | $136.37 | $160.69 | $194.26 | -0.73% |
| October 2026 | $137.15 | $162.33 | $197.63 | +1.02% |
| November 2026 | $142.06 | $168.77 | $206.67 | +3.96% |
| December 2026 | $144.14 | $171.83 | $211.57 | +1.81% |
Click any year to see its month-by-month ICUI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ICUI to range from $115.45 to $211.57 through 2026. The $154.42 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ICUI price prediction for 2027 points to an average of $204.74 (low $166.89, high $263.20) — a potential gain of +33% on today's $154.42. Momentum favours further upside here.
In 2028, ICUI is projected to trade between $178.08 and $294.84, averaging $222.92 — a potential gain of +44% from today's $154.42. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
ICU Medical, Inc.'s 2029 outlook centres on $246.08, within a $193.35 to $332.86 range. That is up +10% on the projected 2028 average. That marks a +59% change versus current levels. Momentum favours further upside here.
By 2030, ICUI could reach as high as $354.35, with a base case around $257.04 and support toward $199.04 — roughly +66% from $154.42. Buyers look set to stay in control over this stretch.
Expect ICUI to range from $221.23 to $405.79 through 2031. The $289.49 average target implies a +87% move from current prices. That is up +13% on the projected 2030 average. Momentum favours further upside here.
The ICUI price prediction for 2032 points to an average of $346.01 (low $261.22, high $492.36) — a potential gain of +124% on today's $154.42. Buyers look set to stay in control over this stretch.
In 2033, ICUI is projected to trade between $284.62 and $550.06, averaging $381.32 — a potential gain of +147% from today's $154.42. That is up +10% on the projected 2032 average. Momentum favours further upside here.
ICU Medical, Inc.'s 2034 outlook centres on $436.13, within a $322.04 to $637.10 range. That is up +14% on the projected 2033 average. That marks a +182% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ICUI could reach as high as $691.82, with a base case around $468.07 and support toward $342.09 — roughly +203% from $154.42. Momentum favours further upside here.
Expect ICUI to range from $514.30 to $1,144.36 through 2040. The $736.81 average target implies a +377% move from current prices. That is up +57% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ICUI price prediction for 2050 points to an average of $1,275.61 (low $824.51, high $2,131.75) — a potential gain of +726% on today's $154.42. Momentum favours further upside here.
Investing $1,000 in ICUI today (≈ 6.475845 ICUI) could be worth
$8,260.65
+$7,260.65 (+726%) by 2050 · US Dollar
Based on the average projected ICUI price of $1,275.61 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICUIwould be worth at today's price.
$1,000 invested in ICUI on Jul 10, 2025 (≈ 7.285444 ICUI) would be worth
$1,125.02
+$125.02 (+12.5%) today · 1.13× · US Dollar
Based on a ICUI entry price of $137.26 vs. today's $154.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $154.97 | $996.45 | -0.4% |
| 1 month ago | $139.83 | $1,104.34 | +10.4% |
| 3 months ago | $125.68 | $1,228.68 | +22.9% |
| 6 months ago | $151.19 | $1,021.36 | +2.1% |
| 1 year ago | $137.26 | $1,125.02 | +12.5% |
| All time (5.0y) ago | $203.95 | $757.15 | -24.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICUI forecast.
Our base-case forecast reaches $310.00 around 2032.
Implied market cap at $310.00: $7.75B
From 2026 to 2035 the average price shows steady growth, with 2027 avg $205.82, 2028 $223.31, 2029 $243.63, and 2030 $257.18.
Beyond 2030, the forecast projects a dramatic rise to an average of $724.20 by 2040 and $1,238.89 by 2050, with ROIs of 367.3% and 699.4% respectively and a bullish sentiment through 2050.
These are estimates, not guarantees, and actual results depend on market conditions and other factors. The 2027–2029 period shows strengthening momentum consistent with the longer-term bullish view.
Tap a question to reveal the answer.
The forecast average price in 2030 is $257.18 with a min of $199.15 and a max of $354.53; the ROI is 66% and sentiment is BULLISH.
Forecasts from 2027 onward show bullish sentiment with rising averages (2027 avg $205.82, 2028 $223.31, 2029 $243.63, 2030 $257.18) and ROI figures (32.8% in 2027, 44.1% in 2028, 57.2% in 2029, 66% in 2030).
Yes; the forecast max by 2040 is $1,124.26 and by 2050 is $2,069.06; the 2050 average is $1,238.89, indicating potential above $1,000.
Current price is $154.97; market cap is $3.87B.
The 30-day picture shows bullish sentiment with RSI14 70, SMA50 $132.43, SMA200 $135.57; price near resistance at $154.97, 30-day range $135.63-$177.07, and support at $129.31.
ICU Medical, Inc. Community Discussion
0Share your ICU Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.